Page 92 - Read Online
P. 92

Mao et al. Chem Synth 2023;3:26  https://dx.doi.org/10.20517/cs.2022.41         Page 19 of 33

               Table 2. Comparison of the sizes, biological models, and bioapplications of nanoscale copper chalcogenides for cancer diagnosis and
               therapy
                Materials                    Size (nm)    Model        Bioapplications             Ref.
                AM@DLMSN@CuS/R848            100          4T1          PTT/IT                      [149]
                Cu S @mSiO -PEG              45           Hep3B        PTT                         [150]
                 9 5
                        2
                Cu Se-PEG-SH                 3.6          4T1          PAI/CT/SPECT/PTT            [135]
                 2-x
                   64
                PEG-[ Cu]CuS NPs             11.9         Hth83 ATC    PET/CT/+PTT/RT              [151]
                CP Nanodots                  16.3         U87MG        CDT                         [152]
                CuS NPs-PEG-Mal              12           4T1          IT                          [153]
                                                                          19
                         19
                Cu S Au@PSI- F/PEG           14           4T1          CT/ FMRI/PTT                [105]
                 7 4-
                Cu Se-NCM                    1.7          Raw          FLI                         [127]
                 2-x
                Gd/CuS@DSPE-PEG-MAL          56           MKN45        FLI/MRI/PTT                 [126]
                Cu Se/Bi Se @PEG             15           HepG2        CT/MRI/CDT/PDT/PTT          [106]
                 2-x
                      2
                        3
                G5-PBA@CuS/cGAMP             3.6          B16-F10      PTT/IT                      [154]
                IR820@CuS/Pt JNMs            142          4T1          FLI/PTT/PDT                 [155]
                AuNBP@CuS                    105          EMT-6        PTT/PDT/CDT                 [156]
                Lipo@ICG@CuS                 145          4T1          FLI/PTT/PDT                 [157]
                Bac@Cu O                     120          CT26         FLI/CDT                     [158]
                     2
                DOX/HCuS@PDA-MB              140          MDA-231      FLI/PTT/Chemotherapy        [159]
                                                                                   19
                                                                      19
               CDT: Chemodynamic therapy; CT: computed tomography; FLI: fluorescence imaging;  FMRI: fluorine-19 ( F) magnetic resonance imaging; IT:
               Immunotherapy; MRI: magnetic resonance imaging; PAI: photoacoustic imaging; PET: positron emission tomography; PDT: photodynamic
               therapy; PTT: photothermal therapy; RT: radiation therapy; SPECT: single-photon emission computed tomography.
               such as limited light penetration depth and hypoxia-related resistance in tumor PDT [152,164-168] . It was a ROS-
               mediated therapeutical method and utilized nano-catalytic medicine and the exogenetic stimulation to
               particularly convert H O  and O  into •OH and  O  intra-tumor. As a result, cancer cells can be effectively
                                                        1
                                    2
                                           2
                                  2
                                                          2
               and safely killed without harming normal tissues [118,166,169] .
               Recently, diverse metal-doped metallic peroxides (MPs), including metal ions and peroxo group (such as Fe,
               Mn, Cu, and Co) nanomaterials [170-172] , have been developed as highly efficient nano-catalytic medicines to
               stimulate the generation of ROS because of their great peroxidase-like activity. Lin et al. reported on the
               manufacture of copper peroxide (CP) nanodots, which were the first samples to have Fenton- competence
               metal peroxide nanomaterials . The CP nanodots were used as an activatable agent to enhance CDT
                                         [152]
               through self-supplying H O  as shown in Figure 12A. In the picture, we could see that, after the
                                       2
                                         2,
               internalization by cells, the CP was resolved in the acidic endo/lysosomal compartments because of the
               sensitivity to pH . The anti-cancer chemo-dynamic effectiveness of CP nanodots was turned out both in
                             [152]
               vitro and in vivo. The specific strategies were shown in Figure 12A: there were lots of cases of chemo-
               dynamic therapy for copper chalcogenides nanoparticles from some researchers [149,173] .

               Wu et al. also confirmed that the Cu-based system is more efficient than conventional Fe-based Fenton
               agents in CDT . A pH-responsive engineered covalent organic framework of CuS was designed in the
                            [118]
               tumor environment by Wang et al., as shown in Figure 12B. Because of the regional excess temperature
               induced by PTT can further improve the CDT efficiency of the nano platform, which could lead to a
               synergistic PTT/chemotherapy/CDT effect . Zuo et al. pioneered a credible paradigm to integrate
                                                      [175]
               photothermal and Fenton-like activities into one nanoplatform, as shown in Figure 12C . It showed the
                                                                                           [174]
               synthesis procedure for CuS@COFs NPs and their application for CDT and PTT.
   87   88   89   90   91   92   93   94   95   96   97